Design Therapeutics (DSGN) Prepaid Assets (2020 - 2026)
Design Therapeutics (DSGN) reported Prepaid Assets of $2.4 million for Q1 2026, down 39.47% on a YoY basis from $4.0 million in Q1 2025, and down 38.99% sequentially from $3.9 million in Q4 2025.
Design Therapeutics (DSGN) Prepaid Assets (2020 - 2026) Analysis & Trends
Design Therapeutics (DSGN) has 7 years of Prepaid Assets data on file, last reported at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 39.47% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 39.47% YoY), and the FY2025 full-year result was $3.9 million, up 203.0% from the prior year.
- Prepaid Assets retreated to $2.4 million in Q1 2026, from $3.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.7 million in Q4 2022 to a low of $112000.0 in Q1 2022.
- A 5-year average of $2.7 million and a median of $2.6 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 62.42% in 2022 and surged 2197.32% in 2023, its largest moves.
- Tracing DSGN's Prepaid Assets over 5 years: stood at $4.7 million in 2022, then plunged by 41.12% to $2.8 million in 2023, then sank by 53.34% to $1.3 million in 2024, then surged by 203.0% to $3.9 million in 2025, then tumbled by 38.99% to $2.4 million in 2026.
- Business Quant data shows DSGN's Prepaid Assets at $2.4 million in Q1 2026, $3.9 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Design Therapeutics | 714.48 Mn | 491.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 3.97 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 4.26 Mn |
| Jun 30, 2022 | 2.35 Mn |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 2.04 Mn |